STEPHEN M. KRANE, M.D.
KRANE SM. Drugs Five Years Later: Etidronate Disodium in the Treatment of Paget's Disease of Bone. Ann Intern Med. 1982;96:619-625. doi: 10.7326/0003-4819-96-5-619
Download citation file:
Published: Ann Intern Med. 1982;96(5):619-625.
Control of Paget's disease of bone has been possible through treatment with agents that decrease bone resorption; calcitonins, diphosphonates, and mithramycin. The pagetic lesion is not, however, cured. Etidronate disodium is one of the diphosphonates. The clinical improvement attained with this drug has to be set against adverse effects, of which pain is probably the most bothersome in practice. Clinical remission can last as long as 2 years after treatment is stopped.
Learn more about subscription options.
Register Now for a free account.
Hospital Medicine, Rheumatology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only